Full Professor in Biochemistry and Molecular Biology (group leader) at Complutense University of Madrid (Spain), with wide experience in cell signaling applied to the knowledge of cancer, liver pathologies and platelets, initially acquired at the National Cancer Institute (USA) and EMBL (Heidelberg). I have leaded several national and international projects funded by public and private grants, some of them in collaboration with physicists to study the biological effects of proton therapy. As a results, I have more than 60 publications in peer review international journals (81% in Q1, 26% in D1, h index=29), 4407 citations in total. Some publications from the last years are: Int J Cancer.152(2):283; Int J Biol Sci. 18(15):5873; Front Cell Dev Biol. 10:1026287; Cell Death Dis. 12(4):348; Cancers 12(8), 2282; Signal Transduct. Target. Ther. 5(1):29; J. Exp. Clin. Cancer Res. 38(1):28; Int J Mol Sci. 22(18):10018.
Full Professor in Biochemistry and Molecular Biology (group leader) at Complutense University of Madrid (Spain), with wide experience in cell signaling applied to the knowledge of cancer, liver pathologies and platelets, initially acquired at the National Cancer Institute (USA) and EMBL (Heidelberg). I have leaded several national and international projects funded by public and private grants, some of them in collaboration with physicists to study the biological effects of proton therapy. As a results, I have more than 60 publications in peer review international journals (81% in Q1, 26% in D1, h index=29), 4407 citations in total. Some publications from the last years are: Int J Cancer.152(2):283; Int J Biol Sci. 18(15):5873; Front Cell Dev Biol. 10:1026287; Cell Death Dis. 12(4):348; Cancers 12(8), 2282; Signal Transduct. Target. Ther. 5(1):29; J. Exp. Clin. Cancer Res. 38(1):28; Int J Mol Sci. 22(18):10018.